HuGE Literature Finder
Records
1
-
5
| Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset. Journal of neuroimmunology 2015 Nov 288 79-86. Wagner Marta, Sobczy?ski Maciej, Karabon Lidia, Bili?ska Ma?gorzata, Pokryszko-Dragan Anna, Pawlak-Adamska Edyta, Cyrul Ma?gorzata, Ku?nierczyk Piotr, Jasek Moni |
| Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. Journal of neuroimmunology 2005 Sep 166 (1-2): 197-201. Lorentzen Aslaug R, Celius Elisabeth G, Ekstrøm Per O, Wiencke Kristine, Lie Benedicte A, Myhr Kjell-Morten, Ling Vincent, Thorsby Erik, Vartdal Frode, Spurkland Anne, Harbo Hanne |
| A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Annals of neurology 2005 Jul 58 (1): 50-7. Kroner Antje, Mehling Matthias, Hemmer Bernhard, Rieckmann Peter, Toyka Klaus V, Mäurer Mathias, Wiendl Hei |
| Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. Journal of neuroimmunology 2004 Mar 148 (1-2): 218-30. Teutsch Suzy M, Booth David R, Bennetts Bruce H, Heard Robert N S, Stewart Graeme |
| CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis. Journal of neuroimmunology 2003 Jul 140 (1-2): 188-93. van Veen Tineke, Crusius J Bart A, van Winsen Lisa, Xia Bing, Barkhof Frederik, Salvador Peña A, Polman Chris H, Uitdehaag Bernard M |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 11, 2022
- Content source: